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Abstract  
Background: The Apgar score has been used globally as an index of early neonatal condition 
for over 60 years. Given advances in healthcare service provision, neonatal resuscitation and 
infant care, its current relevance is unclear. The aim of the study was to determine the 
strength of the relationship between Apgar score at 5 minutes and the risk of neonatal and 
infant mortality, sub-divided by specific causes. 
Methods: Routine discharge and mortality data were linked for all births in Scotland between 
1992 and 2010. The relative risks (RR) of neonatal and infant death of neonates with low (0-
3) and intermediate (4-6) Apgar scores at 5 minutes referent to neonates with normal Apgar 
score (7-10) were calculated by binomial log-linear modelling with adjustment for 
confounders. Analyses were stratified by gestational age at birth, as it was a significant effect 
modifier. Missing covariate data were imputed.  
Findings: 
Complete data were available on 1,029,207 eligible livebirths. Across all gestational strata, 
low Apgar score at 5 minutes was associated with an increased risk of neonatal and infant 
death (deaths due to anomalies were excluded). However, the strength of the association 
(adjusted relative risk, 95% CI; referent to Apgar7-10) was strongest at term (P<0.001). A 
very low Apgar (0-3) was associated with a 359.4-fold risk (95% CI 277.3, 465.9) of early 
neonatal death, a 30.47 (95% CI 17.99, 51.62) -fold risk of late neonatal death and a 50.23 
(95% CI 42.77, 58.98) -fold risk of infant death. Similar associations of a lower magnitude 
were observed for an intermediate Apgar (4-6). The strongest associations were for deaths 
attributed to anoxia. There was no association between Apgar score at 5 minutes and the risk 
of sudden infant death syndrome at any gestational age.  
Interpretation: Low Apgar score at 5 minutes was strongly associated with the risk of 
neonatal and infant death. Our findings support its continued utility in contemporary practice.   
Funding: None   
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Introduction 
The Apgar score has been used globally as an index of health in the immediate neonatal 
period for over 60 years 1. Its ability to assess the need for, and response to, resuscitation has 
led to it being incorporated into national guidelines and World Health Organisation Policy2, 3. 
By virtue of its associations with short and long term mortality, it is also used as an early 
surrogate outcome for strategies designed to achieve the Millennium Development Goal of 
reducing child mortality4.   
 
Evaluation of the Apgar score at 5 minutes in contemporary populations, where neonatal 
intensive care provision is routinely available, has been limited5, 6,7. A population study of 
235,165 births from 1983-1987 suggested an association between low Apgar score at 5 
minutes and neonatal mortality7. Similar associations were reported in a single centre study of 
151,891 singletons from 1988-19985. A more recent population study utilising US birth 
registry data from 1995-2004, also reported increased crude mortality rates among term and 
pre-term infants with low Apgar scores at 5 minutes6. Importantly, however, none of these 
studies adjusted for known risk factors for mortality including birthweight, social class, 
smoking status or previous neonatal death. Furthermore, there was no information on whether 
the deaths were potentially preventable.   
 
In this study we analysed nationally collected data from Scotland where advanced neonatal 
resuscitation resources are routinely available to characterise the neonatal, infant and cause 
specific mortality risk of newborns in relation to their Apgar score 5 minutes. We determined 
whether these associations persisted after adjustment for risk factors known to increase 
mortality rates among term and preterm infants, and following exclusion of deaths due to 
congenital anomalies.  
 5 
 
 
Methods 
Study Population 
We linked four Scotland-wide databases; the Scottish Morbidity Record 02 (SMR02); the 
National Records for Scotland (NRS); the Scottish Stillbirth and Infant Death Survey 
(SSBIDS); and the General Registrar for Scotland’s death certificate database.  The SMR02 
collects information on all women discharged from Scottish maternity hospitals, including 
maternal and infant characteristics, clinical management and obstetric complications (full 
lists of data collected are available here: http://www.adls.ac.uk/nhs-scotland/maternity-
inpatient-and-day-case-smr02/?detail). The SMR02 is subjected to regular quality assurance 
exercises. The most recent compared a 4.4% sample of SMR02 returns (n=2,531) to case 
records and demonstrated that all of the data items used in our study were over 90% complete 
and accurate8. Gestational age has been confirmed by ultrasound in the first half of pregnancy 
in more than 95% of women in the United Kingdom since the early 1990’s. The NRS 
(http://www.nrscotland.gov.uk) registers all stillbirths and infant deaths and the SSBIDS 
(http://www.isdscotland.org/Health-Topics/Maternity-and-Births/Stillbirth-and-Infant-
Deaths/SPIMMR-Background-Information.pdf) then collects additional information from the 
SSBIDS coordinator at the relevant hospital; who is either an obstetrician, paediatrician or 
midwife. The coordinator submits copies of the relevant case summaries, post-mortem 
reports, discharge letters and perinatal mortality meeting reports as well as completing a 
questionnaire. The General Registrar for Scotland collates information from death certificates 
including the primary and secondary causes of death (http://www.gro-scotland.gov.uk).  The 
advisory committee of the Information Services Division (ISD) of the National Services 
Scotland awarded approval for records’ access and linkage.   
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Inclusion criteria and definitions 
We obtained SMR02 data on all infants delivered in Scotland between 1st January 1992 and 
31st December 2010 inclusive, the latter equating to the most recent data available at the time 
of data extraction. Our analyses were restricted to singleton births, in women aged over 10 
years, with a gestational age at delivery between 24 and 44 weeks inclusive. We excluded 
infant deaths due to congenital anomalies or isoimmunisation.  Death ascribed to congenital 
anomaly was defined as any structural or genetic defect incompatible with life or potentially 
treatable but causing death. 
 
Postcode of residence is recorded on the SMR02 record and is used to allocate individuals to 
an area-based socioeconomic decile of the general population using the 2004 Scottish Index 
of Multiple Deprivation (SIMD) (http://www.scotland.gov.uk/Publications/2005/01 
/20458/49127). The index is derived from 31 area markers of deprivation measures across the 
domains of health, education, housing, current income, employment access and crime, that 
are applied to each postcode data zones. There are 6,505 data zones across Scotland with a 
mean population of 750. 
 
Apgar score at 5 minutes of age was categorised into three ordinal groups; low (Apgar 0-3), 
intermediate (Apgar 4-6) and normal (Apgar 7-10)2.  The primary outcomes studied were: 
early neonatal (from birth to up to seven days of life) deaths, late neonatal (from day seven up 
to day 28), and overall neonatal (up to four weeks) and overall infant deaths (up to one year). 
The secondary outcome was cause specific mortality.  Sudden infant death syndrome (SIDS) 
was defined as infant deaths for which the primary cause was recorded as an International 
Classification of Diseases 10 (ICD 10) code of R95 or an ICD 9 code of 798.09.  Neonatal 
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causes were coded using a modification of the Wigglesworth paediatric classification, 
including anoxia and infection10. The definition of anoxia was broad and included hypoxia, 
acidosis, and asphyxia.  In preterm neonates, hyaline membrane disease was included as an 
additional cause of death, in contrast lung immaturity is restricted by definition to neonates 
born under 27 weeks gestation and was not considered as a secondary outcome. 
 
Confounders and risk factors  
We adjusted the risk of death for maternal age, parity, socioeconomic deprivation, year of 
delivery, marital status, smoking status, history of neonatal death, mode of delivery (vaginal, 
abdominal) and timing of delivery (elective included all induced labours and programmed 
caesarean sections, unplanned included all the spontaneous onset labours and emergency 
caesarean sections), sex of the baby and birthweight (categorised according to sex,  gestation 
–specific centiles :  1st-10th centile, 11th-90th centile and > 90th centile). The 11th-90th centile 
category was treated as the referent category for the regression models and the 1-10th centile 
referred to the small for gestation category. Gestation of delivery was examined in stratified 
analyses in accordance with recent recommendations; 24-31+6, 32-33+6, 34-36+6, 37-38+6, 39-
40+6, 41-41+6, ≥ 42 weeks11.  
 
Statistical Analyses 
Median and interquartile ranges were used for continuous variables and Kruskal Wallis test 
for descriptive statistics. Chi-square tests were used for comparison of categorical variables 
between groups. Relative risks (RR) of the outcomes were modelled with a binomial log-
linear regression model before and after adjustment for confounders. Missing values for 
confounders were imputed (n=5) and the regression models were performed with imputed 
values replacing missing values. The significance of interaction terms was assessed using the 
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likelihood ratio test. The level of p<0.05 was considered as statistically significant. 
Sensitivity analysis was performed to examine whether the associations between Apgar 
scores and mortality in the dataset with the complete set of covariates differed from those in 
the imputed dataset. In addition, sensitivity analysis was performed to test whether the 
associations differed across epochs of year of delivery (four epochs: 1992-1996, 1997-2000, 
2001-2005 and 2006-2010). All analyses were performed with Stata (version 12, StataCorp 
LP, College Station, TX).  
 
Results 
Between 1st January 1992 and 31st December 2010, there were 1,062,390 deliveries in 
Scotland. We excluded 15,426 (1.5%) non-singleton deliveries, 1,367 (0.13%) with a 
gestational age outside the range 24 to 44 weeks gestation, 5,158 (0.49%) stillbirths, 1,999 
(0.19%) infant deaths due to congenital anomalies or rhesus isoimmunisation, and 9,792 
(0.92%) where the Apgar score at 5 minutes of age was not recorded. Some records had 
multiple exclusions. Therefore, the study group comprised the remaining 1,029,207 
deliveries. 
 
Among these deliveries, there were 1,395 (0.14%) neonatal deaths, of which 967 (0.09%) 
were early neonatal deaths and 428 (0.04%) were late neonatal deaths. Overall, there were 
2,307 (0.22%) infant deaths. 1,050 (45.5%) were born at term (37 weeks and over), of which 
388 (37%) were due to SIDS, 245 (23.3%) were due to anoxia, and 57 (5.43%) were due to 
infection.  1,257 infant deaths (54.5% of total infant deaths) were born preterm, with 275 
(21.9%) attributed to lung immaturity, 201 (16%) attributed to hyaline membrane disease, 
190 (15.1%) attributed to infection, 120 (9.5%) attributed to anoxia and 80 (6.4%) attributed 
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to SIDS. Figure 1 demonstrates a flowchart of the selected cohorts including the 
denominators for each analysis.  
 
Table 1 shows the maternal characteristics, delivery details and frequency of the primary 
outcomes relative to the Apgar grouping at 5 minutes. The majority of neonates (98.46%) had 
a normal Apgar score at 5 minutes. Women who delivered infants with a low Apgar (0-3) at 
5 minutes were more likely to be young, smokers, multiparous and have an obstetric history 
of neonatal death compared with women who delivered neonates with a normal Apgar at 5 
minutes. A low Apgar score at 5 minutes was more frequent among infants delivered preterm 
or by caesarean section.  
 
The crude rate of neonatal and infant mortality declined markedly and progressively with 
advancing gestational age (Supplementary Table 1) and with increased Apgar score at 5 
minutes. However, there was a significant interaction between gestational age (p<0.001) and 
Apgar score category at 5 minutes, hence, subsequent analyses were stratified by gestational 
age. On the contrary, the interaction of Apgar score category at 5 minutes with birth-weight 
centile was not significant (p=0.36), nor the interaction of Apgar score at 5 minutes with 
epochs of year of delivery (p=0.26). The relative risk of infant death associated with low 
Apgar score at 5 minutes became progressively greater with advancing gestational age 
(Figure 2, Supplementary Table 2). The relative risk of neonatal and infant mortality 
associated with a low Apgar score at 5 minutes peaked at 41 to 41+6 weeks, and subsequently 
declined, although remaining highly statistically significant.  The patterns of absolute and 
relative risks of death were not materially altered when the analysis was restricted to 
complete cases (Supplementary Table 3). Supplementary Table 4 presents the adjusted 
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relative risk for neonatal and infant mortality of other risk factors complimentary to low and 
intermediate Apgar scores.  
 
Table 2 and Supplemental Figure 1show the absolute infant mortality rates and the cause 
specific mortality rates for term and preterm infants stratified by Apgar scoring at 5 minutes. 
Among term infants, the association between low Apgar and the risk of death was strongest 
for deaths due to anoxia (relative risk 961.7, 95% CI 681.3, 1357.5). However, low Apgar at 
5 minutes was also associated with death attributed to infection (relative risk 49.3, 95% CI 
24.1, 100.9), although the association was clearly weaker than that for anoxia.  Among 
preterm infants, there was a similar pattern of stronger associations with death attributed to 
anoxia (relative risk 141.7, 95% CI 90.1, 222.8) than with infection (relative risk 13.0, 95% 
CI 9.1, 18.7). Additionally, there was an association between low Apgar at 5 minutes and the 
risk of death attributed to hyaline membrane disease.  In both term (p=0.68) and preterm 
(p=0.97) infants mortality attributable to SIDS was unrelated to the Apgar score at 5 minutes.  
Preterm infants were more than three times likely to die from SIDS than term neonates 
independent of Apgar score at 5 minutes (i.e. 14 infant deaths per 10,000 live-born among 
preterm neonates with normal Apgar score at 5 minutes as compared to 4 infant deaths per 
10,000 live-born among term neonates with normal Apgar score).  
 
Discussion 
The Apgar score was first described more than 60 years ago1, 12. Despite huge changes in 
paediatric care and massive falls in the risk of infant death in the intervening period, we 
found that the Apgar score at 5 minutes was still extremely strongly associated with the risk 
of neonatal and infant death in Scotland between 1992 and 2010.  The associations with 
neonatal and infant mortality were present at both term and preterm gestations and robust to 
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adjustment for a wide range of confounders13. We demonstrate that a low Apgar score at 5 
minutes was more strongly associated with neonatal and infant mortality attributable to 
anoxia or infection with an additional association with hyaline membrane disease in preterm 
infants. The associations were, however, cause specific. For example, there was no 
significant association between Apgar score at 5 minutes and the risk of SIDS, the leading 
single cause of post neonatal infant death. 
 
There is increasing recognition that there is substantial variability in outcomes among 
neonates delivered at 37 and beyond completed weeks, despite all being classed as “term”14. 
We therefore examined gestation cut points for stratification in accordance with recent 
recommendations11. Previous studies stratified the risk of neonatal mortality in relation to low 
Apgar score at 5 minutes by birthweight rather than by gestation, despite birthweight being a 
function of gestational age and intrauterine growth7, 15, 16.  Our analysis demonstrated that 
gestational age rather than birthweight is an effect modifier of this relationship. In premature 
infants, a low Apgar score may reflect intrinsic physiological immaturity and inadequate 
capacity for response rather than abnormal autonomic, cardiovascular and respiratory 
function in term infants17, 18.  
 
Gestational age at birth has consistently been shown to exhibit an inverse association with 
neonatal and infant mortality19. The net effect of a low Apgar score at 5 minutes on the 
relative risk of both neonatal and infant mortality is thereby smaller for premature infants 
than observed at term.  Although the Apgar score is associated with mortality at all 
gestations5-7, 20, the magnitude of the effect changes across the distribution of gestational ages 
because the background mortality risk of each gestational group varies. Hence, a normal 
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score in preterm infants, unlike full term infants, does not necessarily predict a good 
outcome13.   
 
To our knowledge, this is the first study linking the effect of a low Apgar score at 5 minutes 
with specific causes of infant mortality. At both term and preterm gestations, infants with a 
low Apgar score at 5 minutes were more likely to die from a cause attributable to anoxia 
rather than other causes. Fetal hypoxia and acidosis, as detected by cord blood gas, are 
frequently associated with a reduction in the Apgar score5, 21. Similarly, maternal and fetal 
infections have been associated with lower Apgar scores22, 23. Although a nested case control 
study of 148 cases reported an inverse trend with Apgar at 5 minutes score and risk of 
SIDS24, we did not observe this. This may reflect our greater sample size, as our findings are 
consistent with two larger case control studies25, 26.  
 
Our study included more than one million deliveries.  We included all eligible deliveries in 
Scotland over a nineteen year period, thereby avoiding selection bias and facilitating 
extrapolation to other populations with similar baseline and ethnic characteristics. We linked 
four national datasets to maximise data completeness. The routine data sources are subject to 
quality assurance checks and have been shown to perform well in terms of completeness and 
accuracy.  The detail provided by these datasets allowed us to examine a range of different 
outcomes and adjust for an extensive series of potential confounders and consider effect 
modifiers. We used robust methodology to calculate the relative risk of the outcome for low 
and intermediate Apgar scores at 5 minutes compared with neonates with a normal Apgar 
score with and without adjustment for covariates20.  We acknowledge that our analyses had 
some limitations; Apgar score at 5 minutes is not subject to quality control measures but 
reflects routine clinical practice 27. The individual components of the Apgar score at 5 
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minutes were not available to examine which was the strongest predictor of mortality, but our 
findings add weight to the continuation of the Apgar score at 5 minutes in its current form. 
We did not have data on the Apgar score at 1 minute, but there is evidence that the Apgar 
score at 5 minutes has greater predictive performance 15. We assumed that the population 
remained relatively stable without infants selectively leaving Scotland and thereby 
introducing systematic error and that the complete dataset for the multivariable models were 
reflective of the population. That the effect size in the imputed models is not substantially 
attenuated in comparison to complete cases supports this assumption. 
 
The Apgar score was developed to provide an early assessment of neonatal condition and 
stratify care when healthcare resources and effective interventions were limited.  Our study 
demonstrates that sixty years after its introduction it continues to be prognostic for neonatal 
and infant mortality in contemporary developed populations.  
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Panel: Research in context 
Systematic Review 
PubMed and MEDLINE were searched for reports published until February 2014. Search terms for 
Apgar score (keyword: Apgar*) and infant mortality (keywords: neonatal death, neonatal mortality, 
infant death, infant mortality, neonate and infant) were combined. The reference lists of the selected 
papers were hand-searched for other potentially relevant papers. We have cited all the relevant reports 
in the main text but we were primarily interested in studies relevant to our research question and 
referring to contemporary populations1-3. 
 
Interpretation 
The Apgar score at 5 minutes of life, is an aggregate score of five readily identifiable neonatal 
characteristics; skin colour, heart rate, respiratory effort, muscle tone and reflexes. Each category is 
assigned a score of 0, 1 or 2 depending on the observed condition. Despite recent advances in neonatal 
intensive care and routine provision of neonatal resuscitation we confirm that 60 years after its 
introduction the Apgar score at 5 minutes is still predictive of neonatal and infant mortality. In 
accordance with national guidelines we categorised Apgar score in three categories (low, intermediate 
and normal) 4. We confirm that infants with low and intermediate Apgar score have a substantially 
increased risk of death within the first year of life and for the first time demonstrate that these 
associations are independent of other confounders/risk factors and particularly marked for term 
infants. Our novel cause specific analyses demonstrate that the strongest associations were observed 
for deaths attributed to anoxia. Our study supports the ongoing clinical utility of Apgar scores in 
contemporary populations.  
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Figure 1: Definition of eligible cohort and analysis sample 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
 
 
 
 
 
 
 
ICH: Intracranial haemorrhage, SIDS: Sudden infant death syndrome 
Linked deliveries in Scotland from 1992-2010 (N=1,062,390) 
Records excluded (N=33,183): 
Multiple pregnancies (N=15,426) 
Gestational age <24 or >44 weeks (N=1,367) 
Stillbirths (N=5,158) 
Infant deaths due to congenital anomalies or isoimmunisation (N=1,999) 
Missing data for Apgar scoring at 5 minutes (N=9,792) 
 
 
 
Singleton live-born between 24 to 44 weeks gestation (N=1,029,207) 
Early neonatal deaths (N=967) 
Survivors during early neonatal period (N=1,028,240) 
 
Late neonatal deaths (N=428) 
Survivors during late neonatal period (N=1,027,812) 
 
Neonatal deaths (N= 1,395) 
Survivors during neonatal period (N=1,027,812) 
 
Infant deaths (N=2,307) 
Survivors during infant period (N=1,026,900) 
 
 
 
Infant deaths at term (N=1,051) 
Survivors at term during infant period 
(N=969,675): 
SIDS (N=388) 
Anoxia (N=245) 
Infection (N=57) 
Hyaline Membrane Disease (N=6) 
Birth Trauma (N=6) 
ICH (N=6) 
Other haemorrhage (N=7) 
Other paediatric causes (N=26) 
Unexplained (not SIDS) (N=19) 
Unrecorded (N=291) 
 
 
 
Preterm Infant deaths (N=1,257) 
Preterm survivors during infant 
period (N=57,225): 
SIDS (N=80) 
Anoxia (N=120) 
Infection (N=190) 
Hyaline Membrane Disease (N=201) 
Lung Immaturity (N=275) 
Birth Trauma (N=3) 
ICH (N=39) 
Other haemorrhage (N=19) 
Other paediatric causes (N=83) 
Unexplained (not SIDS) (N=9) 
Unrecorded (N=238) 
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Figure 2: Relative risks and 95% confidence intervals (CIs) of neonatal and infant 
mortality in relation to Apgar score at 5 minutes stratified per gestational age category 
in the complete dataset (n=1,029,207). 
 
 
 
 
 
Figure 2A (top panel): Adjusted relative risks and 95% confidence intervals (CIs) of early 
and late neonatal mortality for neonates with low (0-3) and intermediate (4-6) Apgar score at 
5 minutes referent to neonates with normal Apgar score at 5 minutes.  
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Figure 2B (lower panel): Adjusted relative risks and 95% confidence intervals (CIs) of 
neonatal and infant mortality for neonates with low (0-3) and intermediate (4-6) Apgar score 
at 5 minutes referent to neonates with normal Apgar score at 5 minutes.  
Relative risks have been adjusted for maternal age, maternal smoking, maternal marital status, 
history of neonatal death, parity, Social Deprivation Score (SIMD), neonatal sex, birth-weight 
categories, timing and mode of delivery and year of delivery. Horizontal dashed line indicates 
unity
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Table 1: Maternal Characteristics, delivery details and outcomes in relation to Apgar 
scores at 5 minutes of life (N=1,029,207). 
  Apgar 7-10 Apgar 4-6 Apgar 0-3 
No (%) 1,013,363 
(98.46%) 
10,202 (0.99%) 5,642 (0.55%) 
Maternal Age (years) (IQR) 29.0 (24-33) 28 (23-32) 28.0 (24-32) 
Maternal height (cm) (IQR) 163 (158-167) 162 (157-166) 162 (157-166) 
Parity 
0 
1 
≥ 2 
 
459,696 (45.57%) 
347,324 (34.43%)  
 
201,821 (20.01%)    
 
5,604 (55.20%) 
2,770 (27.29%) 
1,778 (17.51%) 
 
2,491 (44.29%) 
1,789 (31.81%) 
1,344 (23.90%) 
Smoking 
Current Smokers 
Ex-smokers 
Non-smoker 
 
250,276 (27.31%) 
86,347 (9.42%) 
579,759 (63.27%) 
 
2,825 (31.08%)  
879 (9.67%) 
5,385 (59.25%) 
 
1,689 (34.62%) 
452 (9.27%) 
 
2,737 (56.11%) 
Social Deprivation Score (SIMD) 
1 (lowest social class) 
2 
3 
4 
5 
6 
7 
8 
9 
10 (highest social class) 
 
144,910 (14.36%) 
120,440 (11.93%) 
106,781 (10.58%) 
101,291 (10.04%) 
94,759 (9.39%) 
90,325 (8.95%) 
87,654 (8.68%) 
88,099 (8.73%) 
88,256 (8.74%) 
86,816 (8.60%) 
 
1,599 (15.76%) 
1,337 (13.18%) 
1,139 (11.23%) 
1,039 (10.24%) 
 
971 (9.57%) 
 
909 (8.96%) 
 
873 (8.60%) 
 
780 (7.69%) 
 
756 (7.45%) 
 
743 (7.32%) 
 
842 (14.37) 
 
757 (13.51%) 
 
636 (11.35%) 
 
588 (10.49%) 
 
527 (9.40%) 
 
503 (8.97%) 
 
464 (8.28%) 
 
440 (7.85%) 
 
412 (7.35%) 
 
436 (7.78%) 
Married 483,364 (62.66%) 4,518 (58.42%) 2,763 (60.82%) 
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Previous Neonatal Death 
0 
≥  1 
 
839,779 (99.56%) 
3,731 (0.44%) 
 
8,637 (99.28%) 
63 (0.72%) 
 
4,151 (99.40%) 
25 (0.60%) 
Previous Stillbirth  
0 
≥  1 
 
 
838,207 (99.37%) 
 
5,348 (0.63%) 
 
 
8,646 (99.7%) 
 
55 (0.63%) 
 
 
4,143 (99.21%) 
 
33 (0.79%) 
Previous miscarriage 
0 
≥  1 
 
804,415 (79.40%) 
208,677 (20.60%) 
 
8,169 (80.09%) 
2,031 (19.91%) 
 
4,442 (78.74%) 
1,199 (21.26%) 
Previous termination 
0 
≥  1 
 
908,666 (89.69%)  
104,437 (10.31%) 
 
9,096 (89.69 %) 
1,104 (10.82%) 
 
5,039 (89.33%) 
602 (10.67%) 
Mode of delivery 
Cephalic SVD 
Non cephalic SVD 
Instrumental delivery 
Elective Caesarean Section 
Emergency Caesarean Section 
 
679,777 (69.36%) 
2,767 (0.28%) 
90,410 (9.22%) 
 
80,591 (8.22%) 
 
126,611 (12.92%) 
 
5,224 (52.84%) 
228 (2.31%) 
866 (8.76%) 
 
377 (3.81%) 
 
3,192 (32.28%) 
 
3,245 (58.47%) 
207 (3.73%) 
378 (6.81%) 
 
249 (4.49%) 
 
1,471 (26.50%) 
Gestation at delivery (IQR) 40 (39-41) 39 (37-40) 39 (36-40) 
Birthweight (g) (IQR) 3,420  
(3,080-3,760) 
3,210  
(2,660-3,650) 
3,130 
(2,390-3,580) 
Preterm 54,693 (5.40%) 2,213 (21.69%) 1,576 (27.93%) 
Infant Sex 
Female 
Male 
 
495,281 (48.88%) 
518,040 (51.52%) 
 
4,424 (43.38%) 
5,775 (56.62%) 
 
2,694 (47.75%)  
2,948 (52.25%) 
Outcomes    
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Early Neonatal Deaths (n) 316 (0.03%) 171 (1.68%) 480 (8.51%) 
Late Neonatal Deaths (n) 312 (0.03%) 66 (0.65%) 50 (0.89%) 
Neonatal Deaths (n) 628 (0.06%) 237 (2.32%) 530 (9.39%) 
Infant Deaths (n) 1,446 (0.14%) 283 (2.77%) 578 (10.24%) 
 
 
Figures are numbers (percentages) unless otherwise stated.  
Abbreviations: IQR: interquartile range, NND: neonatal death, SB: stillbirth, SVD: 
spontaneous vaginal delivery. 
 
Numbers (%) missing data:  maternal age 10 (<0.001), maternal height 195,792 (19.02), 
parity 4,590 (0.45), smoking status 98,858 (9.61), SIMD 4,125 (0.40), marital status 245,510 
(23.85), previous NND 172,821 (16.79), previous SB 172,775 (16.79), previous miscarriage 
274 (0.03), previous termination of pregnancies 263 (0.03), mode of delivery 33,614 (3.27), 
gestational age 0 (0), sex 45 (<0.001), birthweight 397 (0.04).  
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Table 2: Crude and cause specific infant mortality rate for preterm and term infants 
 
 Mortality rate (per 1,000 births) Apgar 7-10 Apgar 4-6 Apgar 0-3 p-value* 
Term 
(N=970,725) 
Infant Mortality rate 8.21 (7.65, 8.80) 86.37 (67.26, 109.18) 477.3 (413.65, 547.20) <0.001 
 Infant mortality rate attributed to SIDS 4.01 (3.62, 4.43) 3.79 (0.78, 11.06) 2.58 (0.00, 14.38) 0.68 
 Infant mortality rate attributed to anoxia 0.42 (0.30, 0.57) 54.00 (39.11, 72.67) 40.16 (343.11, 46.83) <0.001 
 Infant mortality rate attributed to infection 0.47 (0.34, 0.63) 3.79 (0.78, 11.06) 23.19 (10.61, 43.98) <0.001 
Preterm 
(N=58,482) 
Infant Mortality rate 120.49 (111.51, 130.00) 967.01 (847.02, 1097.8) 2436.55 (2226.4, 2656.3) <0.001 
 Infant mortality rate attributed to SIDS 14.05 (11.07, 17.58) 9.99 (1.21, 36.06) 16.75 (20.03, 60.38) 0.97 
 Infant mortality rate attributed to anoxia 4.44 (2.85, 6.61) 79.40 (45.45, 128.63) 628.93 (501.82, 776.68) <0.001 
 Infant mortality rate attributed to infection 23.08 (19.22, 27.49) 138.14 (91.98, 199.03) 301.06 (212.84, 412.60) <0.001 
 Infant mortality rate attributed hyaline 
membrane disease 
20.50 (16.87, 24.68) 220.16 (161.03, 293.49) 363.78 (266.56, 483.76) <0.001 
 
Values presented as mortality per 10,000 births with 95% confidence intervals. SIDS: Sudden infant death syndrome 
*Chi squared test for trend comparing mortality rates across Apgar categories 
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Supplementary Table 1: Neonatal and infant mortality per 10,000 births according to Apgar score and stratified for gestational age 
 
 
Values presented as mortality per 10,000 births of that gestational age strata with 95% confidence intervals. 
*Chi squared test for trend comparing mortality rates across Apgar categories 
 
 
 
 
 
 
 
 
 
 
 
 
 
 Neonatal Mortality Infant Mortality 
   Apgar Score     Apgar Score   
Gestation Crude Rate 7-10 4-6 0-3 P* Crude Rate 7-10 4-6 0-3 P* 
           
24-31+6 972 (909.1, 1037.8) 528.3 (475.1, 585.5) 1737.3 (1503.6, 1991.1) 3545.7 (3220.2, 3881.4) <0.001 1206 (1136.6, 1278) 734.6 (672.3, 800.8) 2037.2 (1787.5, 2305.1) 3918.3 (3584.9, 4259.3) <0.001 
           
32-33+6 80.1 (61.2, 22.5) 33.4 (21.2, 50.1) 324.5 (163.1, 573.2) 948.9 (629.3, 1359.4) <0.001 113.5 (90.7, 140.1) 66.9 (49.0, 89.1) 324.5 (163.1, 573.2) 1021.9 (689.9, 1443.0) <0.001 
           
34-36+6 18 (14.2, 22.5)  10.9 (7.9, 14.6) 44.1 (12.0, 112.5) 595.7 (399.5, 849.5) <0.001 40.3 (34.5, 46.8) 32.9 (27.6, 38.9) 66.2 (24.3, 143.4) 638.3 (434.8, 898.7) <0.001 
           
37-38+6 5.9 (4.8, 7.1) 3.5 (2.7, 4.5) 43.9 (17.7, 90.2) 415.2 (292.5, 570.2) <0.001 15.4 (13.7, 17.4) 12.8 (11.2, 14.5) 68.9 (34.5, 123.0) 461.4 (331.6, 623.0) <0.001 
           
39-40+6 4.2 (3.6, 4.8) 2.0 (1.6, 2.4) 59.7 (37.9, 89.5) 415.7 (336.8, 506.9) <0.001 9.8 (9.0, 10.7) 7.5 (6.8, 8.3) 75.3 (50.5, 108) 438.1 (357.1, 531.3) <0.001 
           
41-41+6 4.6 (3.8, 5.6) 1.9 (1.3, 2.5) 99 (61.4, 150.9) 532.2 (387.8, 710.2) <0.001 9.5 (8.2, 10.8) 6.5 (5.5, 7.7) 108.4 (66.8, 162.2) 569.3 (419.8, 752.1) <0.001 
           
≥ 42 5.8 (3.6, 8.8) 2.7 (1.3, 4.9) 71.4 (14.8, 207.3) 584.4 (270.7, 1080.4) <0.001 10.8 (7.8, 14.7) 6.7 (4.3, 9.9) 142.9 (52.6, 308.3) 649.4 (315.8, 1161.7) <0.001 
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Supplementary Table 2: Unadjusted and adjusted relative risks of neonatal and infant mortality in relation to Apgar score  
RR (95% CI): Relative risk with 95% confidence intervals 
Horizontal bar (-) suggests small or nil number of events to specific strata so the RR is close to zero or not calculable.  
Adjusted for maternal age, parity; socioeconomic deprivation; year of delivery, marital status, smoking status, previous history of neonatal death, previous history of 
miscarriage, previous history of termination of pregnancy; mode of delivery, and urgency of delivery, offspring sex and birthweight centile 
The analysis was performed in the complete dataset with imputed values for missing values of confounders (n=1,029,207). 
 Early Neonatal Mortality Late Neonatal Mortality Neonatal Mortality Infant Mortality 
Gestation Apgar Unadjusted RR (95% CI) 
Adjusted RR 
(95% CI) 
Unadjusted RR 
(95% CI) 
Adjusted RR 
(95% CI) 
Unadjusted RR 
(95% CI) 
Adjusted RR 
(95% CI) 
Unadjusted RR 
(95% CI) 
Adjusted RR 
(95% CI) 
 
Preterm 
 
7-10 
4-6 
0-3 
 
1 
14.28 (11.51,17.71) 
50.46 (42.79, 59.52) 
 
1 
14.33 (11.53, 17.82) 
46.05 (38.87, 54.55) 
 
1 
7.71 (5.75, 10.32) 
7.17 (4.96, 10.39) 
 
1 
7.34 (5.46, 9.87) 
6.72 (4.62, 9.77) 
 
1 
11.00 (9.29, 13.03) 
29.47 (25.78, 33.68) 
 
1 
10.87 (9.16, 12.89) 
26.94 (23.49, 30.90) 
 
1 
8.02 (6.91, 9.31) 
20.22 (18.02, 22.70) 
 
1 
7.83 (6.74, 9.09) 
18.58 (16.50, 20.92) 
 
Term 7-10 
4-6 
0-3 
1 
54.53 (36.36, 81.77) 
369.8 (274.9, 497.5) 
1 
44.49 (30.81, 64.22) 
359.4 (277.3, 465.9) 
1 
11.94 (5.77, 24.7) 
45.48 (25.34, 81.60) 
1 
8.71 (4.40, 17.25) 
30.47 (17.99, 51.62) 
1 
32.37 (23.03, 45.48) 
200.3 (157.9, 254.2) 
1 
24.95 (18.32, 33.96) 
177.8 (145.0, 218.0) 
1 
11.10 (8.36, 14.73) 
59.35 (49.02, 71.85) 
1 
8.81 (6.81, 11.40) 
50.23 (42.77, 58.98) 
 
Gestational age categories        
24-31+6 7-10 
4-6 
0-3 
1 
4.22 (3.38, 5.27) 
11.34 (9.53, 13.50) 
1 
4.44 (3.48, 5.66) 
10.16 (8.31, 12.43) 
1 
2.45 (1.81, 3.32) 
2.02 (1.37, 2.97) 
1 
2.52 (1.86, 3.42) 
1.94 (1.31, 2.86) 
1 
3.29 (2.77, 3.91) 
6.71 (5.85, 7.70) 
1 
3.36 (2.79, 4.04) 
6.10 (5.23, 7.11) 
1 
2.77 (2.38, 3.22) 
5.33 (4.73, 6.02) 
1 
2.83 (2.42,3.32) 
4.88 (4.29,5.57) 
 
32-33+6 7-10 
4-6 
0-3 
1 
11.84 (4.69, 29.87) 
52.30 (26.56, 103.0) 
1 
9.85 (3.89, 24.93) 
48.11 (24.26, 95.40) 
1 
7.52 (2.41, 23.50) 
2.51 (0.32, 19.34) 
1 
6.92 (2.17, 22.06) 
2.23 (0.28, 17.57) 
1 
9.70 (4.77, 19.74) 
28.38 (16.41, 49.09) 
1 
8.20 (4.02, 16.75) 
26.05 (14.96, 45.37) 
1 
4.85 (2.54, 9.28) 
15.28 (9.70, 24.06) 
1 
4.18 (2.18,8.03) 
14.19 
(8.96, 22.46) 
 
34-36+6 7-10 
4-6 
0-3 
1 
7.92 (2.75, 22.86) 
99.38 (57.13, 172.9) 
1 
6.67 (2.30, 19.35) 
80.27 (45.59, 141.3) 
1 
 -  
8.46 (1.99, 35.85) 
1 
- 
7.18 (1.67, 30.88) 
1 
6.28 (1.87, 21.08) 
46.25 (21.96, 97.42) 
1 
3.47 (1.25, 9.68) 
45.08 (28.10, 72.31) 
1 
2.01 (0.89, 4.54) 
19.39 (13.20, 28.49) 
1 
1.87 (0.83, 4.23) 
17.07 (11.58, 25.18) 
 
37-38+6 7-10 
4-6 
0-3 
1 
22.08 (8.47, 57.62) 
276.5 (165.7, 461.3) 
1 
20.12 (7.67, 52.79) 
262.6 (156.6, 445.4) 
1 
5.99 (1.40, 24.82) 
11.43 (2.76, 47.36) 
1 
5.57 (1.34, 23.20) 
9.87 (2.37, 41.17) 
1 
12.47 (5.72, 27.20) 
118.0 (78.70, 177.0) 
1 
11.47 (5.24, 25.11) 
110.2 (72.94, 166.4) 
1 
5.40 (2.95, 9.87) 
36.14 (25.99, 50.25) 
1 
5.04 (2.75, 9.22) 
32.21 (23.05, 45.00) 
 
39-40+6 7-10 
4-6 
0-3 
1 
56.20 (33.39, 94.60) 
406.37 (285.7, 577.9) 
1 
45.62 (26.97, 77.17) 
376.3 (262.8, 538.7) 
1 
7.40 (2.31, 23.63) 
39.47 (19.54, 79.77) 
1 
6.60 (2.05, 21.22) 
35.39 (17.41,71.93) 
1 
36.53 (20.62, 64.72) 
183.1 (119.3, 281.0) 
1 
24.97 (15.84, 39.37) 
193.1 (143.9, 256.3) 
1 
10.03 (6.89,14.61) 
58.35 (46.94,72.53) 
1 
8.51 (5.82,12.42) 
51.57 (41.30, 64.40) 
 
41-41+6 
 
 
 
7-10 
4-6 
0-3 
1 
90.41 (47.43, 172.4) 
530.8 (310.2, 908.1) 
1 
68.21 (35.44-131.3) 
434.5 (250.9, 752.3) 
1 
29.24 (8.88, 96.23) 
138.9 (46.86, 411.9) 
1 
16.28 (5.52, 48.01) 
60.95 (22.81,162.8) 
1 
53.18 (31.55-89.64) 
286.0 (188.0, 435.1) 
1 
41.12(24.18, 69.91) 
241.9 (157.6, 371.8) 
1 
16.64 (10.75,25.77) 
87.41 (63.23, 120.8) 
1 
14.50 (9.31,22.58) 
78.68 (56.58,109.4) 
≥42 7-10 
4-6 
0-3 
1 
53.24 (12.76, 222.0) 
338.8 (108.7, 1055.8) 
1 
43.98 (10.32, 187.4) 
290.2 (91.70, 918.6) 
1 
- 
101.39 (19.83, 518.4) 
1 
- 
91.27 (18.70,445.5) 
1 
26.62 (7.35, 96.37) 
217.8 (89.75, 528.6) 
1 
21.80 (5.95,79.89) 
187.4 (76.42, 459.6./) 
1 
21.3(8.78,51.64) 
96.79 (47.3, 198.1) 
1 
18.48 (7.52,45.39) 
96.00 (46.83, 196.8) 
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Supplementary Table 3: Unadjusted and adjusted relative risks of neonatal and infant mortality in relation to Apgar score in the 
complete dataset without missing values for confounders (n= 540,974) 
RR (95% CI): Relative risk with 95% confidence intervals 
Horizontal bar (-) suggests small or nil number of events to specific strata so the RR is close to zero or not calculable.  
Adjusted for maternal age, parity; socioeconomic deprivation; year of delivery, marital status, smoking status, previous history of neonatal death, previous history of 
miscarriage, previous history of termination of pregnancy; mode of delivery, and urgency of delivery, offspring sex and birthweight centile
  Early Neonatal Mortality Late Neonatal Mortality Neonatal  Mortality Infant Death Mortality 
Gestation  Apgar  Unadjusted RR (95% CI) 
Adjusted RR 
(95% CI) 
Unadjusted RR 
(95% CI) 
Adjusted RR 
(95% CI) 
Unadjusted RR 
(95% CI) 
Adjusted RR 
(95% CI) 
Unadjusted RR 
(95% CI) 
Adjusted RR 
(95% CI) 
 
Preterm 
 
7-10 
4-6 
0-3 
 
1 
16.48 (12.09, 22.46) 
50.28 (39.28, 64.35) 
 
 
1 
17.14 (12.56, 23.39) 
47.79 (37.26, 61.30) 
 
1 
8.34 (5.37, 12.96) 
9.10 (5.44, 15.22) 
 
1 
8.05 (5.15, 12.58) 
8.80 (5.24, 14.77) 
 
1 
12.55 (9.80, 16.06) 
30.71 (25.11, 37.56) 
 
1 
12.78 (9.97, 16.37) 
29.20 (23.83, 35.76) 
 
1 
9.07 (7.31, 11.25) 
20.43 (17.14, 24.35) 
 
1 
9.10 (7.33, 11.31) 
19.42 (16.30, 23.17) 
Term 7-10 
4-6 
0-3 
1 
68.45 (43.29, 108.2) 
403.3 (282.7, 575.4) 
1 
57.10 (35.94, 90.72) 
361.2 (252.2, 517.3) 
1 
16.94 (8.07, 35.54) 
48.65 (24.84, 95.28) 
1 
13.84 (6.55, 29.24) 
41.54 (21.11, 81.73) 
1 
41.15 (28.31, 59.81) 
214.7 (162.1, 284.4) 
1 
34.16 (23.41, 49.86) 
188.4 (141.7, 250.5) 
1 
13.32 (9.77, 18.17) 
61.82 (49.46, 77.26) 
1 
11.81 (8.64, 16.15) 
55.14 (44.03, 69.06) 
 
Gestational age categories        
24-31+6 7-10 
4-6 
0-3 
 
1 
4.36 (3.16, 6.02) 
10.24 (7.90, 13.26) 
1 
4.38 (3.19, 6.02) 
8.79 (6.79, 11.38) 
1 
2.74 (1.74, 4.31) 
2.57 (1.51, 4.37) 
1 
2.78 (1.77, 4.37) 
2.52 (1.49, 4.27) 
1 
3.54 (2.75, 4.55) 
6.60 (5.36, 8.14) 
1 
3.64 (2.77, 4.78) 
5.88 (4.69, 7.36) 
1 
2.90 (2.33, 3.62) 
4.96 (4.12, 5.96) 
1 
2.92 (2.35, 3.63) 
4.42 (3.67, 5.31) 
32-33+6 7-10 
4-6 
0-3 
1 
19.51 (5.29, 71.89) 
64.73 (23.39, 179.1) 
 
1 
16.35 (4.46, 59.99) 
66.77 (23.84, 187.0) 
1 
3.13 (0.39, 24.85) 
- 
1 
2.37 (0.30, 18.86) 
- 
1 
9.38 (3.39, 25.96) 
24.90(11.76, 52.72) 
1 
7.58 (2.75, 20.91) 
23.37 (10.97, 49.80) 
1 
5.30 (2.04,13.75) 
15.15 (7.97, 28.83) 
1 
4.12 (1.59, 10.66) 
13.02 (6.80, 24.95) 
          
34-36+6 7-10 1 
14.22 (3.93, 51.50) 
89.75 (36.83, 218.7) 
1 
13.27 (3.64, 48.41) 
86.52 (35.23, 212.5) 
1 
- 
9.44 (1.22, 72.83) 
1 
- 
9.21 (1.17, 72.28) 
1 
6.77 (2.03, 22.62) 
47.49 (22.63, 99.66) 
1 
6.33 (1.88, 21.25) 
45.46 (21.55, 95.89) 
1 
3.11 (1.14, 8.51) 
17.98 (9.59, 33.71) 
1 
3.12 (1.14, 8.54) 
16.31 (8.65, 30.76) 
4-6 
0-3 
          
37-38+6 7-10 
4-6 
0-3 
1 
16.26 (4.82, 54.83) 
195.7 (102.4, 373.8) 
1 
15.21 (4.48, 51.65) 
184.1 (95.98, 353.1) 
1 
10.33 (2.42, 44.12) 
- 
1 
8.61 (2.00, 37.11) 
- 
1 
13.20 (5.21, 33.41) 
95.32 (54.37, 167.1) 
1 
11.83 (4.65, 30.08) 
86.91 (49.37, 153.0) 
1 
6.49 (3.18,13.21) 
29.27 (17.81, 48.12) 
1 
6.05 (2.97, 12.36) 
27.01(16.36, 44.60) 
          
39-40+6 7-10 
4-6 
0-3 
1 
82.17 (42.10, 160.4) 
384.2 (224.8, 656.8) 
1 
68.17 (34.68, 134.0) 
347.3 (202.0, 597.1) 
1 
10.40 (2.46, 43.87) 
52.88 (20.28, 137.9) 
1 
8.58 (2.02, 36.51) 
47.12 (17.98, 123.5) 
1 
43.96 (24.97, 77.39) 
207.1 (135.6, 316.2) 
1 
36.53 (20.62, 64.73) 
182.9 (119.2, 280.7) 
1 
13.48 (8.42, 21.58) 
57.71 (41.35, 80.54) 
1 
11.30 (7.03, 18.16) 
49.92 (35.65, 69.89) 
          
41-41+6 7-10 
4-6 
0-3 
1 
152.2 (62.34, 371.7) 
1002.3 (458.1, 2193.0) 
1 
121.9 (49.44, 300.5) 
846.5 (383.4, 1869.2) 
1 
41.00 (12.88, 130.6) 
159.0 (54.61, 463.0) 
1 
30.84 (9.45, 100.7) 
136.5 (46.01, 404.7) 
1 
90.21 (46.11, 176.5) 
528.0 (298.8, 932.9) 
1 
70.97 (35.94, 140.2) 
446.4 (250.7, 794.7) 
1 
23.63 (13.98, 39.94) 
138.3 (93.17, 205.4) 
1 
21.50 (12.64, 36.57) 
130.3 (87.16, 194.7) 
          
≥ 42 7-10 
4-6 
0-3 
1 
22.38 (2.51, 199.5) 
232.0 (58.95, 912.9) 
1 
28.53 (3.08, 263.9) 
199.6 (50.72, 785.6) 
1 
- 
80.99 (8.51, 770.7) 
1 
- 
75.02 (7.16, 785.9) 
1 
12.79 (1.58, 103.5) 
165.7 (53.61, 512.1) 
 
1 
11.26 (1.35, 94.05) 
161.8 (53.98, 485.1) 
1 
11.94 (2.75, 51.90) 
92.79 (36.86, 233.6) 
1 
11.11 (2.53, 48.82) 
90.58 (38.18, 214.9) 
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Supplementary Table 4: Risk factors independent of Apgar score category for neonatal and infant mortality in term and preterm 
neonates 
 Early Neonatal Mortality Late Neonatal Mortality Infant Mortality 
Gestation Co-variates Adjusted RR (95% CI) 
p-value Adjusted RR 
(95% CI) 
p-value Adjusted RR 
(95% CI) 
p-value 
 
Preterm 
 
Maternal age (per one year increase) 
 
Former or never smokers 
Current smokers  
 
SIMD (per one decile increase from most 
deprived to least deprived areas) 
 
Not currently married 
Married 
 
Nulli-parity 
Parity  
 
No history of NND 
History of NND 
 
Abdominal delivery 
Vaginal delivery 
 
Unplanned delivery 
Planned delivery 
 
Birthweight 11th -90th centile 
Birthweight ≤ 10th centile 
Birthweight >90th centile 
 
Female gender 
Male gender 
 
Year of delivery (per one year increase) 
 
 
0.99 (0.97-1.01) 
 
1 
1.18 (0.93-1.50) 
 
0.96 (0.92-1.00) 
 
 
1 
1.26 (0.98-1.63) 
 
1 
0.87 (0.66-1.15) 
 
1 
2.09 (1.01-4.34) 
 
1 
0.92 (0.69-1.22) 
 
1 
0.60 (0.45-0.80) 
 
1 
0.94 (0.64-1.37) 
1.22 (0.85-1.75) 
 
1 
1.07 (0.93-0.98) 
 
0.96 (0.93-0.98) 
 
0.52 
 
 
0.16 
 
0.05 
 
 
 
0.08 
 
 
0.32 
 
 
0.05 
 
 
0.55 
 
 
0.001 
 
 
0.73 
0.27 
 
 
0.55 
 
<0.001 
 
0.97 (0.94-1.00) 
 
1 
0.94 (0.64-1.38) 
 
0.94 (0.88-1.01) 
 
 
1 
1.04 (0.68-1.59) 
 
1 
1.19 (0.79-1.79) 
 
1 
1.88 (0.58-6.05) 
 
1 
0.72 (0.46-1.14) 
 
1 
0.61 (0.39-0.97) 
 
1 
1.22 (0.69-2.16) 
0.91 (0.48-1.75) 
 
1 
1.58 (1.10-2.28) 
 
0.98 (0.95-1.02) 
 
0.08 
 
 
0.74 
 
0.10 
 
 
 
0.85 
 
 
0.41 
 
 
0.29 
 
 
0.16 
 
 
0.04 
 
 
0.49 
0.79 
 
 
0.01 
 
0.32 
 
0.98 (0.97-0.99) 
 
1 
1.16 (0.97-1.37) 
 
0.96 (0.93-0.99) 
 
 
1 
1.15 (0.95-1.39) 
 
1 
1.00 (0.83-1.22) 
 
1 
1.75 (1.01-3.06) 
 
1 
0.90 (0.73-1.10) 
 
1 
0.72 (0.59-0.89) 
 
1 
1.05 (0.81-1.37) 
1.03 (0.78-1.37) 
 
1 
1.20 (1.02-1.41) 
 
0.97 (0.96-0.99) 
 
0.02 
 
 
0.10 
 
0.006 
 
 
 
0.14 
 
 
0.97 
 
 
0.05 
 
 
0.30 
 
 
0.002 
 
 
0.72 
0.84 
 
 
0.02 
 
0.002 
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Term Maternal age (per one year increase) 
 
Former or never smokers 
Current smokers 
 
SIMD (per one decile increase from most 
deprived to least deprived areas) 
 
Not currently married 
Married 
 
 
Nulli-parity 
Parity  
 
No history of NND 
History of NND 
 
Abdominal delivery 
Vaginal delivery 
 
Planned delivery 
Planned delivery 
 
Birthweight 11th-90th centile 
Birthweight ≤ 10th centile 
Birthweight >90th centile 
 
Female gender 
Male gender 
 
Year of delivery (per one year increase) 
1.02 (0.99-1.06) 
 
1 
0.66 (0.43-1.00) 
 
0.95 (0.90-1.01) 
 
 
1 
1.18 (0.81-1.73) 
 
 
1 
0.57 (0.39-0.85) 
 
1 
1.83 (0.25-13.31) 
 
1 
0.37 (0.26-0.52) 
 
1 
0.88 (0.63-1.24) 
 
1 
1.17 (0.76-1.80) 
0.91 (0.52-1.58) 
 
1 
0.77 (0.57-1.05) 
 
0.99 (0.96-1.02) 
0.11 
 
 
0.05 
 
0.10 
 
 
 
0.39 
 
 
 
0.006 
 
 
0.55 
 
 
<0.001 
 
 
0.49 
 
 
0.49 
0.73 
 
 
0.10 
 
0.59 
0.92 (0.88-0.97) 
 
1 
1.27 (0.76-2.10) 
 
0.91 (0.83-1.00) 
 
 
1 
1.20 (0.68-2.13) 
 
 
1 
1.58 (0.89-2.79) 
 
1 
2.84 (0.38-21.00) 
 
1 
0.67 (0.38-1.16) 
 
1 
1.66 (1.01-2.71) 
 
1 
2.15 (1.26-3.66) 
0.17 (0.021.26) 
 
1 
1.00 (0.64-1.59) 
 
0.93 (0.89-0.99) 
0.004 
 
 
0.36 
 
0.06 
 
 
 
0.52 
 
 
 
0.12 
 
 
0.31 
 
 
0.15 
 
 
0.045 
 
 
0.005 
0.08 
 
 
0.98 
 
0.02 
 
0.96 (0.95-0.98) 
 
1 
1.68 (1.39-2.03) 
 
0.94 (0.91-0.98) 
 
 
1 
0.88 (0.72-1.09) 
 
 
1 
1.40 (1.14-1.72) 
 
1 
3.14 (1.61-6.12) 
 
1 
0.62 (0.50-0.77) 
 
1 
0.98 (0.81-1.19) 
 
1 
1.59 (1.28-1.97) 
0.60 (0.40-0.90) 
 
1 
1.10 (0.93-1.31) 
 
0.98 (0.96-0.99) 
<0.001 
 
 
<0.001 
 
0.001 
 
 
 
0.25 
 
 
 
0.001 
 
 
0.001 
      
 
     <0.001 
 
 
0.85 
 
 
<0.001 
0.01 
 
 
0.28 
 
0.03 
 
The relative risks (RR) and 95% confidence intervals (CIs) are adjusted for all the above factors with additional adjustment for Apgar score 
category at 5 minutes. 
SIMD; Scottish Index of Multiple Deprivation, NND: neonatal death. 
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Supplementary Figure 1: Crude and cause specific infant mortality rate for term and 
preterm infants 
 
 
 
Figure 1A (top panel): Overall and cause specific infant mortality for term infants (N=970,725). 
Expressed as number of deaths per 10,000 term births utilising a log10 scale. 
Figure 1B (lower panel): Overall and cause specific infant mortality for preterm infants 
(N=58,482). Expressed as number of deaths per 10,000 term births utilising a log10 scale. 
SIDS: Sudden infant death syndrome 
Overall infant 
mortality rate SIDS Anoxia Infection 
Apgar 7-10 8.21 4.01 0.42 0.47 
Apgar 4-6 86.37 3.79 54.00 3.79 
Apgar 1-3 477.13 2.58 401.59 23.19 
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Overall 
infant 
mortality 
rate 
SIDS Anoxia Infection 
Hyaline 
membrane 
disease 
Apgar 7-10 120.49 14.05 4.44 23.08 20.50 
Apgar 4-6 967.01 9.99 79.40 138.14 220.16 
Apgar 1-3 2436.55 16.75 628.93 301.06 363.78 
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